Advertisement

Retail Crime pp 325-353 | Cite as

Theft of Medicines from Hospitals as Organised Retail Crime: The Italian Case

  • Ernesto U. Savona
  • Marco Dugato
  • Michele Riccardi
Chapter
Part of the Crime Prevention and Security Management book series (CPSM)

Abstract

Theft of medicines is emerging as the new frontier of pharmaceutical crime and of organised retail crime. It is attractive to criminals due to the high profits and the relatively low risk, and it is facilitated by many asymmetries of the legal market. Using data retrieved from open sources and institutional reports, this chapter focuses on the theft of medicines from hospitals that occurred in Italy between 2006 and 2014. It describes what types of medicines are stolen, where and how, and it tests two hypotheses: (1) that stolen medicines are ‘laundered’ and resold on the legal market, exploiting the vulnerabilities of the pharmaceutical supply-chain; and (2) that organised crime—especially Italian mafias and Eastern European groups—plays a crucial role in this criminal activity, supported by a network of corrupt officials and white-collar criminals.

Keywords

Theft of medicine Organised theft Pharmaceutical crime 

References

  1. AIFA - Agenzia Italiana del Farmaco (Pharmaceutical National Italian Agency. (2015). Operation Volcano - The Herceptin Case. Rome, Italy: AIFA. Retrieved September 11, 2017, from https://www.researchgate.net/profile/Domenico_Giorgio/publication/303445021_Operation_Volcano_-_The_Herceptin_Case/links/57431e6308ae9f741b38aec9/Operation-Volcano-The-Herceptin-Case.pdf
  2. Bate, R. (2008). Making a Killing: The Deadly Implications of the Counterfeit Drug Trade. Washington, DC: American Enterprise Institute for Public Policy Research.Google Scholar
  3. Becucci, S. (2014). Le collusioni con la mafia nell’Italia odierna. Quaderni di Sociologia, 31, 153–157.CrossRefGoogle Scholar
  4. Calderoni, F. (2011). Where Is the Mafia in Italy? Measuring the Presence of the Mafia across Italian Provinces. Global Crime, 12(1), 41–69.CrossRefGoogle Scholar
  5. Clarke, R. (1999). Hot Products: Understanding, Anticipating and Reducing Demand for Stolen Goods. London: Home Office, Policing and Reducing Crime Unit, Research, Development and Statistics Directorate.Google Scholar
  6. Clarke, R. V. (1995). Situational Crime Prevention. Crime and Justice, 19, 91–150.CrossRefGoogle Scholar
  7. Cohen, L. E., & Felson, M. (1979). Social Change and Crime Rate Trends: A Routine Activity Approach. American Sociological Review, 44(4), 588.CrossRefGoogle Scholar
  8. Cornish, D. B., & Clarke, R. (2008). The Rational Choice Perspective. In R. Wortley & L. Mazerolle (Eds.), Environmental Criminology and Crime Analysis (pp. 21–47). London: Routledge.Google Scholar
  9. Council of Europe. (2015). MEDICRIME Convention - Handbook for Parliamentarians. Council of Europe. Retrieved September 11, 2017, from http://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?documentId=09000016806a9674
  10. eCrime. (2015). FAKECARE. Trento, Italy: Università degli Studi di Trento. Retrieved September 11, 2017, from http://www.fakecare.com/images/pdf/eCrime_Research_Reports_02.pdf
  11. Dugato, M., Favarin, S., & Giommoni, L. (2015). The Risks and Rewards of Organized Crime Investments in Real Estate. British Journal of Criminology, 55(5), 944–965.CrossRefGoogle Scholar
  12. EFPIA - European Federation of Pharmaceutical Industries and Associations. (2012). The pharmaceutical industry in figures. Retrieved September 11, 2017, from http://www.efpia.eu/uploads/Modules/Documentsefpia_figures_2012_final-20120622-003-en-v1.pdf/
  13. Ekwall, D., Brüls, H., & Wyer, D. (2015). Theft of Pharmaceuticals During Transport in Europe. Journal of Transportation Security, 1–6. https://doi.org/10.1007/s12198-015-0162-x CrossRefGoogle Scholar
  14. EMA - European Medicine Agency. (n.d.). Parallel Distribution. Retrieved September 11, 2017, from http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000067.jsp&mid=WC0b01ac0580024594
  15. Espìn, J., & Rovira, J. (2007). Analysis of Differences and Commonalities in Pricing and Reimbursement Systems in Europe. Brussels: Andalusian School of Public Health; Commissioned by the European Commission, Directorate-General Enterprise 2007. Retrieved September 11, 2017, from http://ec.europa.eu/enterprise/sectors/healthcare/files/docs/study_pricing_2007/andalusian_school_public_health_report_pricing_2007_en.pdf
  16. Europol - The European Union’s Law Enforcement Agency. (2011). OCTA 2011. EU Organized Crime Threat Assessment. The Hague, The Netherlands: Europol. Retrieved September 11, 2017, from https://www.europol.europa.eu/sites/default/files/publications/octa2011.pdf
  17. Europol - The European Union’s Law Enforcement Agency. (2013). Italian Organised Crime Threat Assessment. The Hague, The Netherlands.Google Scholar
  18. Eurostat - European statistics. (2012). Population Structure and Ageing. Retrieved April 13, 2016, from http://ec.europa.eu/eurostat/statistics-explained/index.php/Main_Page
  19. Ferwerda, J., & Unger, B. (2016). Organised Crime Infiltration in the Netherlands: Transportation Companies Hiding Transit Crimes. In E. Savona, M. Riccardi, & G. Berlusconi (Eds.), Organised Crime in European Businesses (pp. 35–50). Abingdon: Routledge.Google Scholar
  20. Folino-Gallo, P., Montilla, S., Bruzzone, M., & Martini, N. (2008). Pricing and Reimbursement of Pharmaceuticals in Italy. The European Journal of Health Economics, 9(3), 305–310.CrossRefGoogle Scholar
  21. Fornaro, A. (2014, February 11). Farmaci Introvabili. Nuovo Collegamento. Retrieved September 11, 2017, from https://www.utifar.it/uploads/model_5/1_farmaci_introvabili.pdf
  22. Grimald, P. (2012). Roche Argentina: Fighting Counterfeit Medicines Using a Traceability System based on GS1 Standards. In AAVV (Ed.), 2011/2012 GS1 Healthcare Reference Book (pp. 4–9). Brussels: GS1 Global Office. Retrieved September 11, 2017, from www.gs1.org.ar/documentos/casos%20de%20exito/Caso_Roche.pdf
  23. Guardia di Finanza. (2015, June). Operazione Pharmalab - Ricettavano farmaci provenienti da furti, 9 gli arresti. Retrieved September 11, 2017, from http://www.gdf.gov.it/stampa/ultime-notizie/anno-2015/giugno-2015/operazione-pharmalab-ricettavano-farmaci-provenienti-da-furti-9-gli-arresti
  24. IMPACT. (2013). La Normativa Sulle Farmacie on Line. Retrieved February 27, 2014, from http://www.iss.it/impa/faco/cont.php?id=210&lang=1&tipo=33
  25. Interpol. (2014). Pharmaceutical Crime and Organized Criminal Groups. Lyon: Interpol.Google Scholar
  26. Interpol - The International Police Organization. (2011). The Dangers of Counterfeit Medical Products. Retrieved September 11, 2017, from http://www.interpol.int/Crime-areas/Pharmaceutical-crime/The-dangers
  27. Interpol - The International Police Organization. (2012). Pharmaceutical crime. Lyon: Interpol. Retrieved September 11, 2017, from http://www.interpol.int/content/download/3902/37957/version/17/file/Factsheets_EN_mars2013_DCO04%20web.pdf
  28. Kruisbergen, E. W., Kleemans, E. R., & Kouwenberg, R. F. (2015). Profitability, Power, or Proximity? Organized Crime Offenders Investing Their Money in Legal Economy. European Journal on Criminal Policy and Research, 21(2), 237–256.CrossRefGoogle Scholar
  29. Lodewijkx, H., & Brouwer, B. (2011). Some Empirical Notes on the Epo Epidemic in Professional Cycling. Research Quarterly for Exercise and Sport, 82(4). https://doi.org/10.5641/027013611X13275192112069 CrossRefGoogle Scholar
  30. Mohney, G. (2014). Why Fentanyl-Laced Heroin Is So Dangerous. ABC News. Retrieved September 11, 2017, from http://abcnews.go.com/Health/dangers-fentanyl-laced-heroin/story?id=22374848
  31. Møldrup, C. (2004). The Use of the Terms “Lifestyle Medicines” or “Lifestyle Drugs”. Pharmacy World & Science: PWS, 26(4), 193–196.CrossRefGoogle Scholar
  32. Mrazek, M. F. (2002). Comparative Approaches to Pharmaceutical Price Regulation in the European Union. Croatian Medical Journal, 43(4), 453–461.Google Scholar
  33. ÖBIG - Österreichisches Bundesinstitut für Gesundheitswesen (Austrian Federal Institute for Health Care). (2006). Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States. Brussels: European Commission.Google Scholar
  34. OECD. (2009). Pharmaceutical Consumption. In Health at a Glance 2009: OECD Indicators. Paris: OECD publishing. Retrieved September 11, 2017, from https://doi.org/10.1787/health_glance-2009-46-en
  35. OsMed - Osservatorio Nazionale sull’Impiego dei Medicinali (National Observatory on the Use of Medicines). (2012). L’uso dei farmaci in Italia. Rapporto nazionale anno 2011. Rome: Il Pensiero Scientifico Editore. Retrieved September 11, 2017, from http://www.iss.it/binary/pres/cont/osmed_2011.pdf
  36. Palomo, J., Márquez, J., & Laguna, P. (2016). From Drug Trafficking to Wholesale Trade Business: Organised Crime Infiltration in Spain. In E. Savona, M. Riccardi, & G. Berlusconi (Eds.), Organised Crime in European Businesses (pp. 64–84). Abingdon: Routledge.Google Scholar
  37. Pauwels, K., Huys, I., Casteels, M., De Nys, K., & Simoens, S. (2014). Market Access of Cancer Drugs in European Countries: Improving Resource Allocation. Targeted Oncology, 9(2), 95–110.CrossRefGoogle Scholar
  38. Pharmaceutical Security Institute. (2017). Counterfeit Medicine. Retrieved September 11, 2017, from http://www.psi-inc.org/counterfeitSituation.cfm
  39. Reilly, G. (2012, September 17). Pharmacists Warned Over Use of Cough Syrup to Make Crystal Meth. TheJournal.ie. Retrieved September 11, 2017, from http://www.thejournal.ie/warning-cough-syrup-crystal-meth-598467-Sep2012/
  40. Riccardi, M., Dugato, M., & Polizzotti, M. (2014). The Theft of Medicines from Italian Hospitals. Trento: Università degli Studi di Trento.Google Scholar
  41. Riccardi, M., Dugato, M., Polizzotti, M., & Pecile, V. (2015). The Theft of Medicines from Italian Hospitals, Transcrime Research in Brief, N.2/2015. Trento: Transcrime - Joint Research Centre on Transnational Crime.Google Scholar
  42. Riccardi, M., & Proietto, G. (2017). Illicit Trade of Medical Products. Background Paper for the High-Level Meeting of the Research Project Illicit Trade and Related Crimes Coordinated by the Siracusa Institute.Google Scholar
  43. Riccardi, M., Soriani, C., & Giampietri, V. (2016). Mafia Infiltration in Legitimate Companies in Italy. In E. Savona, M. Riccardi, & G. Berlusconi (Eds.), Organised Crime in European Businesses (pp. 119–140). Abingdon: Routledge.Google Scholar
  44. Safemedicines. (2013, March). National Boards of Pharmacy Releases 2013 Report, 97% of Online Pharmacies Not Recommended - Partnership for Safe Medicines - Working Together to Protect the Safety of Your Drugs. Retrieved February 26, 2017, from http://www.safemedicines.org/2013/03/national-boards-of-pharmacy-releases-2013-report-less-than-1-meet-vipps-criteria-518.html
  45. Sciarrone, R., & Storti, L. (2013). The Territorial Expansion of Mafia-Type Organized Crime. The Case of the Italian Mafia in Germany. Crime, Law and Social Change, 61(1), 37–60. https://doi.org/10.1007/s10611-013-9473-7 CrossRefGoogle Scholar
  46. Sukkar, E., & Smith, H. (2013). Panic in Greek Pharmacies as Hundreds of Medicines Run Short. The Guardian. Retrieved September 11, 2017, from https://www.theguardian.com/world/2013/feb/27/greece-blames-drug-companies-shortages
  47. Tamburini, F. (2013). Grecia, Centinaia di Farmaci Bloccati Dalle Multinazionali. Sanità in Ginocchio. Il Fatto Quotidiano. Retrieved September 11, 2017, from http://www.ilfattoquotidiano.it/2013/03/29/grecia-centinaia-di-farmaci-bloccati-dalle-multinazionali-sanita-in-ginocchio/526250/
  48. TAPA EMEA - Transported Asset Protection Association - Europe, Middle-East and Africa. (2014, July). Vigilant. Retrieved September 11, 2017, from https://www.tapaemea.org/recent/vigilant-july-edition-2014.html
  49. The European House Ambrosetti. (2011). Studio Strategico: i Nuovi Provvedimenti per il Settore del Tabacco: I Fattori di Rischio Economici e Sociali. Retrieved September 11, 2017, from http://www.ambrosetticlub.eu/index.php?option=com_k2&view=item&task=download&id=396&Itemid=0&public=1
  50. The European House-Ambrosetti. (2012). Meridiano Sanità. Le Coordinate della Salute. Rapporto 2012. The European House-Ambrosetti. Retrieved September 11, 2017, from http://www.ambrosetti.eu/video-e-documenti/
  51. Transcrime. (2010). FAKES – Fighting Against Brand Counterfeiting in Three Key European Member States. Towards a More Comprehensive Strategy. Milan-Trento: Transcrime. Retrieved September 11, 2017, from http://transcrime.cs.unitn.it/tc/890.php
  52. Transcrime. (2013). Project NOP Security 2007–2013: Mafias Investments. Report Line 1. Rome: Italian Ministry of Interior. Retrieved September 11, 2017, from http://www.investimentioc.it/index.htm
  53. Turchetti, G., Pani, M., Cannizzo, S., Antonel, A., & Rossi, E. (2016). Thefts of Medicines from Hospital Pharmacies: A European Challenge. European Journal of Hospital Pharmacy, 23(1, Suppl 1), A111–A112.Google Scholar
  54. UNICRI - United Nations Interregional Crime and Justice Research Institute. (2012). Counterfeit Medicines and Organized Crime. Retrieved February 4, 2017, from http://www.unicri.it/topics/counterfeiting/medicines/report/Ctf_medicines_and_oc_advance_unedited2013.pdf
  55. Vander Beken, T. (2007). The European Pharmaceutical Sector and Crime Vulnerabilities. Antwerpen: Maklu.Google Scholar
  56. WHO - World Health Organization. (2010). Bulletin of the World Health Organization: Growing Threat from Counterfeit Medicines. February 22, 2017, Retrieved February 22, 2017, from http://who.int/bulletin/volumes/88/4/10-020410/en/#
  57. Zlatareva, A. (2015). Analysis of the Reimbursement Policy in Central and Eastern European Countries: The Policy of Poland, Romania, Hungary and the Czech Republic, Part II. World Journal of Pharmacy and Pharmaceutical Research, 4(9), 64–76.Google Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  • Ernesto U. Savona
    • 1
  • Marco Dugato
    • 1
  • Michele Riccardi
    • 1
  1. 1.Transcrime, Università Cattolica del Sacro CuoreMilanoItaly

Personalised recommendations